⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SNY News
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
Global Orphan Drugs Market Size, Share and Trends Analysis Report, 2026-2033 | Market to Reach USD 434.9 Billion as Gene and Cell Therapies Drive 9.0% CAGR
globenewswire.com
JNJ
AZN
NVS
VRTX
SNY
AMGN
MRK
BMY
PFE
Latent TB Diagnostics Market Report Now Available — Reveals Why Rising Prevalence and Rapid, Multiplex Testing Are Expanding Options Even as Cost Pressure Squeezes the Market
globenewswire.com
XRAY
DHX
QGEN
SNY
Immune Checkpoint Inhibitors Market Size, Share, Trends, and Global Forecast to 2030 | Next-Generation Targets and Combination Therapies Create New Growth Opportunities
globenewswire.com
BMY
GSK
INCY
NVS
JNJ
SNY
EXR
UEG Week: Teva and Sanofi’s Duvakitug Maintained Long-Term Positive Outcomes in New Phase 2b Data for Ulcerative Colitis and Crohn’s Disease
globenewswire.com
SNY
TEVA
Global Viral Vector and Plasmid DNA Manufacturing Market, 7th Edition: Forecast to 2035 | 9.73% CAGR Unlocks USD 2.16 Billion CMO and Gene Therapy Opportunity
globenewswire.com
CRL
CAT
TMO
NVS
BNTX
SNY
ISPE Names Sanofi S.A. the 2026 ISPE Facility of the Year Awards (FOYA) Overall Winner for its Modulus Project
prnewswire.com
SNY
Enable Injections Announces Approval in Japan for CirCLIQ® Injector based on enFuse® On-Body Delivery System
globenewswire.com
SNY
Press Release: Sanofi breaks ground on new state-of-the-art insulin manufacturing facility in Germany
globenewswire.com
SNY
Press Release: Sanofi breaks ground on new state-of-the-art insulin manufacturing facility in Germany
globenewswire.com
SNY
Australia mRNA Therapeutics Market Size and Forecast to 2035 by Application and Disease Indication | 19% CAGR Drives USD 1.78 Billion Opportunity Across Influenza and RSV
globenewswire.com
PFE
ARCT
MRNA
BNTX
AZN
GSK
SNY